Evidence map›Paper›PMID 27858330›Full record

ArticleInternational journal of hematology2017

Primary mediastinal large B-cell lymphoma in Japanese children and adolescents.

Tomoo Osumi, Fumiko Tanaka, Tetsuya Mori, Reiji Fukano, Masahito Tsurusawa, Koichi Oshima, Atsuko Nakazawa, Ryoji Kobayashi

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Tomoo OsumiChildren's Cancer Center, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-0074, Japan. osumi-t@ncchd.go.jp.
Fumiko TanakaDepartment of Pediatrics, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Kanagawa, Japan.
Tetsuya MoriDepartment of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Reiji FukanoDepartment of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
Masahito TsurusawaDepartment of Pediatrics, Aichi Medical University, Nagakute, Aichi, Japan.
Koichi OshimaDepartment of Pathology, Kurume University School of Medicine, Fukuoka, Japan.
Atsuko NakazawaDepartment of Pathology, National Center for Child Health and Development, Tokyo, Japan.
Ryoji KobayashiDepartment of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
National Center For Child Health and Development · JPAichi Medical University · JPKurume University · JPNational Hospital Organization Kyushu Cancer Center · JPSaiseikai Ibaraki Hospital · JPSapporo Hokuyu Hospital · JPSt. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is the first case series to describe primary mediastinal large B-cell lymphoma (PMLBL) patients in children and adolescents in Asia. We retrospectively identified 17 PMLBL patients diagnosed between 1991 and 2014; in seven of these cases, the diagnosis was confirmed by central review, representing 1.0% of all NHL and 2.2% of all B-NHL cases registered. All patients were teenagers, including seven adolescents, with a median age of 14 years (range 12-18 years). Ten patients were male, and seven were female. The 5-year EFS and OS rates were 81.9 and 84.4%, respectively. All seven recent cases remain alive, of which three received rituximab combination therapy. Incidence, characteristics, and outcome varied considerably from those of Western populations. Further studies, including molecular analysis, are warranted.

Indexed as

Mediastinal NeoplasmsAdolescentAntineoplastic Combined Chemotherapy ProtocolsAsian PeopleChildDisease-Free SurvivalFemaleHumansIncidenceLymphoma, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Non-HodgkinMaleRetrospective StudiesRituximabSurvival RateRituximabAdolescentsChildrenNon-Hodgkin lymphomaPMLBLPrimary mediastinal large B-cell lymphoma

Identifiers

PMID27858330
OpenAlexW2556444437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.